Detection of soluble EpCAM in malignant ascites to predict overall survival in patients treated with catumaxomab.
Andreas Seeber
No relevant relationships to disclose
Ioana Braicu
No relevant relationships to disclose
Gerold Untergasser
No relevant relationships to disclose
Mani Nassir
No relevant relationships to disclose
Normann Steiner
No relevant relationships to disclose
Dominic Fong
No relevant relationships to disclose
Laura Botta
No relevant relationships to disclose
Guenther Gastl
No relevant relationships to disclose
Heidi Fiegl
No relevant relationships to disclose
Alain G Zeimet
No relevant relationships to disclose
Agnieszka Martowicz
No relevant relationships to disclose
Jalid Sehouli
No relevant relationships to disclose
Gilbert Spizzo
Consultant or Advisory Role - Fresenius Biotech (U)